In the present study we provide evidences that CPT treatment from 0–36 h activates signatures of EMT and cellular survival along with early apoptotic factors in cancer population both in vitro (HCT-116, SW620, A549 cells) and in vivo (Apc floxed colorectal carcinoma model) conditions. The gene discussed is APC; the disease is colorectal carcinoma.